Related Experiment Video
Updated: Apr 20, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Lipid rafts, KCa/ClCa/Ca2+ channel complexes and EGFR signaling: Novel targets to reduce tumor development by lipids?
Maxime Guéguinou1, Audrey Gambade1, Romain Félix1
1Inserm, UMR1069, Nutrition, Croissance et Cancer, Tours F-37032, France; Université François Rabelais, Tours F-37032, France.
Abstract:
Membrane lipid rafts are distinct plasma membrane nanodomains that are enriched with cholesterol, sphingolipids and gangliosides, with occasional presence of saturated fatty acids and phospholipids containing saturated acyl chains. It is well known that they organize receptors (such as Epithelial Growth Factor Receptor), ion channels and their downstream acting molecules to regulate intracellular signaling pathways. Among them are Ca2+ signaling pathways, which are modified in tumor cells and inhibited upon membrane raft disruption. In addition to protein components, lipids from rafts also contribute to the organization and function of Ca2+ signaling microdomains. This article aims to focus on the lipid raft KCa/ClCa/Ca2+ channel complexes that regulate Ca2+ and EGFR signaling in cancer cells, and discusses the potential modification of these complexes by lipids as a novel therapeutic approach in tumor development. This article is part of a Special Issue entitled: Membrane channels and transporters in cancers.
Insights
Membrane lipid rafts organize calcium (Ca2+) and Epidermal Growth Factor Receptor (EGFR) signaling. Targeting these raft lipid-protein complexes offers a novel therapeutic strategy for cancer by modulating Ca2+ and EGFR pathways.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Membrane lipid rafts are specialized plasma membrane nanodomains rich in cholesterol and sphingolipids.
- These rafts organize signaling molecules, including receptors like EGFR and ion channels, crucial for cellular communication.
- Calcium (Ca2+) signaling pathways are altered in cancer and sensitive to raft disruption.
Purpose of the Study:
- To investigate lipid raft KCa/ClCa/Ca2+ channel complexes involved in Ca2+ and EGFR signaling in cancer cells.
- To explore the potential of lipid modifications within these complexes as a therapeutic strategy for cancer treatment.
Main Methods:
- The study focuses on the structural and functional aspects of lipid raft-associated ion channel complexes.
- Analysis involves understanding the role of specific lipids in organizing Ca2+ and EGFR signaling microdomains.
- The research discusses therapeutic interventions targeting these lipid-protein complexes.
Main Results:
- Lipid rafts play a critical role in organizing Ca2+ and EGFR signaling pathways in cancer cells.
- Alterations in raft composition can impact the function of KCa/ClCa/Ca2+ channel complexes.
- These lipid-protein complexes are implicated in the regulation of tumor development.
Conclusions:
- Lipid raft KCa/ClCa/Ca2+ channel complexes are key regulators of Ca2+ and EGFR signaling in cancer.
- Modulating the lipid composition of these raft complexes presents a promising novel therapeutic avenue for cancer treatment.
- Understanding these lipid-protein interactions is vital for developing targeted cancer therapies.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Mitogens and the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression